Video

Ray-tracing IOL modeling in AMD patients

Author(s):

OT Staff Reports
Conferences|ARVO

Uwe Oberheide, MD, discusses the key findings of his virtual ARVO 2021 presentation on modeling of IOLs for patients with AMD by ray-tracing.

Uwe Oberheide, MD, of the University of Applied Sciences, Cologne, Germany, discusses the key findings from his virtual ARVO 2021 presentation on modeling of intraocular lenses (IOLs) for patients with age-related macular degeneration (AMD) by ray-tracing.

See more ARVO content

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
Related Content
USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy
November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Study examines the use of AI–based detection of diabetic retinopathy in the US
November 13th 2024

Study examines the use of AI–based detection of diabetic retinopathy in the US

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

Researchers offer insights into wet AMD: Study reveals potential to enhance anti-VEGF therapy with experimental drug to preserve vision
November 8th 2024

Researchers offer insights into wet AMD: Study reveals potential to enhance anti-VEGF therapy with experimental drug to preserve vision

FDA grants fast track status to FELIQS’ FLQ-101 for ROP
November 6th 2024

FDA grants fast track status to FELIQS’ FLQ-101 for ROP

© 2024 MJH Life Sciences

All rights reserved.